Trial Profile
Clinical Trials Insight: 700044056
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 May 2009
Price :
$35
*
At a glance
- Drugs IMX 942 (Primary)
- Indications Nosocomial infections
- Focus Adverse reactions
- Sponsors Inimex Pharmaceuticals
- 05 May 2009 New trial record.